A generalizable cross-continent prediction of esophageal squamous cell carcinoma using the oral microbiome

Authors:

Abstract
Esophageal squamous cell carcinoma (ESCC) is a disease with limited tools for early screening and a poor prognosis. Symptoms typically appear late, and early cancer is hard to detect without endoscopic screening, which is inaccessible in most high-risk areas. Saliva is easily accessible, and its microbiome composition can serve as a marker for upper gastrointestinal tract disease. We studied the potential utility of an oral microbiome signature for ESCC in South Africa, a region with a high incidence of the disease. In a cohort of 48 ESCC patients and 110 controls, we found marked alterations in the oral microbiome in patients with ESCC, including significantly reduced alpha diversity and increased Fusobacterium nucleatum . We devised machine learning models that classify ESCC using microbiome data, finding good performance on held-out samples (area under receiver operating characteristic curve of 0.96), and demonstrated generalization to data across independent studies conducted in different geographic regions (0.64-0.81). Overall, our results demonstrate the potential of the oral microbiome to serve as a non-invasive screening tool for ESCC.
All Related Versions
Funding Information
  • NIH/NCI (CA238433-S1)
  • NIH/NCI (P30CA013696-50)
  • South African Medical Research Council
  • South African National Research Foundation
  • German Federal Ministry of Education and Research (01KA2220B)
  • Wellcome Trust and the UK Foreign, Commonwealth & Development Office

This publication has 63 references indexed in Scilit: